mirage

Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression

ABACUS/Manakin Repository

Show simple item record

dc.contributor.author Pulido, Federico spa
dc.contributor.author Delgado, Rafael spa
dc.contributor.author Pérez-Valero, Ignacio spa
dc.contributor.author González-García, Juan spa
dc.contributor.author Miralles, Pilar spa
dc.contributor.author Arranz, Alberto spa
dc.contributor.author Hernando Jeréz, María Asunción spa
dc.contributor.author Arribas, José R. spa
dc.date.accessioned 2013-11-27T17:26:42Z
dc.date.available 2013-11-27T17:26:42Z
dc.date.issued 2008 spa
dc.identifier.citation Pulido, F., Delgado, R., Pérez-Valero, I., González-García, J., Miralles, P., Arranz, A., ..., & Arribas, J. R. (2008). Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression. Journal of Antimicrobial Chemotherapy, 61(6), 1359-1361. spa
dc.identifier.uri http://hdl.handle.net/11268/975
dc.description.abstract Data are scarce on the long-term efficacy of lopinavir/ritonavir monotherapy for the maintenance of HIV suppression. Four years of results of patients randomized to monotherapy in the Only Kaletra (OK) pilot clinical trial are presented. Twenty-one HIV-infected patients with suppressed HIV replication (<50 copies/mL) for at least 6 months and without previous failure while receiving a protease inhibitor-based regimen started lopinavir/ritonavir monotherapy. Follow-up was performed within the OK pilot clinical trial during the first 2 years and according to routine clinical practice during the 3rd and 4th years. Fourteen patients (67%) remain on monotherapy and with RNA <50 copies/mL (intention-to-treat analysis, with missing patients scored as failures). Five patients (24%) had virological rebound and all of them were successfully re-suppressed by adding two nucleosides. No major protease inhibitor mutations were found. Our data support the long-term efficacy and safety of lopinavir/ritonavir monotherapy for the maintenance of HIV suppression, a finding that must be confirmed in larger studies. spa
dc.language.iso eng spa
dc.title Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression spa
dc.type article spa
dc.description.impact 4.328 JCR (2008) Q1, 8/51 Infectious diseases, 17/91 Microbiology, 31/219 Pharmacology & pharmacy spa
dc.identifier.doi 10.1093/jac/dkn103 spa
dc.rights.accessRights closedAccess en
dc.subject.unesco Sida spa
dc.peerreviewed Si spa


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record